Skip to main content
. Author manuscript; available in PMC: 2020 May 18.
Published in final edited form as: Curr Diab Rep. 2019 Nov 25;19(12):148. doi: 10.1007/s11892-019-1280-9

Table 3.

Key recommendations for the design and research of mobile and Internet interventions for disadvantaged and vulnerable persons with diabetes

Access issues Use technology patients already access and use
Compensate for participation, but do not pay for technology to understand potential real-word use and sustainability
If providing/paying for technology, consider cost analyses to determine sustainability
Program design and usability Tailor content on the individual level (e.g., person-reported personal data)
Apply existing standards to make digital design acceptable to persons of all health literacy and numeracy levels
Consider literacy and numeracy when designing content and functionality; report how design accommodates all levels
For now, disparities in internet access persist, so consider non-internet-dependent technology
Test interventions for usability with the target population; report usability data (not just self-reported satisfaction)
The human element Utilize personnel familiar with/known to the study population (e.g., community health workers)
Trained personnel can tailor to individuals’ needs and experiences with the technology and may help overcome mistrust
Systematically evaluate when and how humans can and should be used to improve the reach or effectiveness of digital interventions
Understand the user population Report data on socioeconomic status (e.g., income, education, insurance status), health literacy and numeracy of study samples or study catchment populations to inform next steps for interventions
When possible, examine differential effects by socioeconomic status, health literacy status
When possible, examine differential engagement with the intervention by socioeconomic and/or health literacy status
Use more agile science Focus on comparative effectiveness/superiority trials, pragmatic trials and cost analyses rather than efficacy trials with a treatment-as-usual control group
Studies with an active comparison are more likely to engage disadvantaged/vulnerable persons with diabetes
Use adaptive study designs to address the need for continued quality improvement and rapid iteration
Long-term evaluation Studies with interventions lasting longer than 3 or 6 months are needed
Studies with post-intervention follow-up periods are needed
Economic evaluations Make efforts to understand costs and savings associated with digital interventions to determine if effects are “worth” costs associated with the technologies
Consider cost analyses in two ways: (1) without providing/paying for technology, (2) evaluating whether providing/paying for technology is cost-effective in light of savings associated with improvements in health outcomes
Conduct studies in low-/top-income countries More studies in low-/top-income countries are needed
Develop interventions specifically for the population or describe rigorous efforts to adapt existing interventions to the context